FEATURED/ARCHIVES (06/05/24)
Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder · May 2008
Articles (Manuscripts-Versions)
PubMed Central>International Clinical Psychopharmacology
MDMA-Assisted Therapy: A New Treatment Model for Social Anxiety in Autistic Adults · March 2015
Articles
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Comparing the Effectiveness of Paroxetine, Attention Modification Program and Combination of Both on Improving Social Anxiety Symptoms · October 2012
Articles
Basic and Clinical Neuroscience
Exposure Therapy and Sertraline in Social Phobia: I-Year Follow-Up of a Randomised Controlled Trial · April 2003
Articles
British Journal of Psychiatry
Analysis of Health-Related Quality of Life and Costs Based on a Randomised Clinical Trial of Escitalopram for Relapse Prevention in Patients with Generalised Social Anxiety Disorder · August 2008
Articles
International Journal of Clinical Practice
Paroxetine Reduces Social Anxiety in Individuals with a Co-Occurring Alcohol Use Disorder · March 2007
Articles (Manuscripts-Versions)
PubMed Central>Journal of Anxiety Disorders
Social Anxiety Disorder: Associated Conditions and Therapeutic Approaches · December 2022
Articles
Cureus
The Cost Effectiveness of Psychological and Pharmacological Interventions for Social Anxiety Disorder: A Model-Based Economic Analysis · October 2015
Articles
PLOS ONE
Common Changes in Cerebral Blood Flow in Patients with Social Phobia Treated with Citalopram or Cognitive-Behavioral Therapy · May 2002
Articles
JAMA Psychiatry
Fluvoxamine CR in the Long-Term Treatment of Social Anxiety Disorder: The 12- to 24-Week Extension Phase of a Multicentre, Randomized, Placebo-Controlled Trial · December 2003
Articles
International Journal of Neuropsychopharmacology
An Open-Label Trial of Escitalopram in Children and Adolescents with Social Anxiety Disorder · December 2007
Abstracts
Journal of Child and Adolescent Psychopharmacology
D-Cycloserine Augmentation of Cognitive Behavioral Group Therapy of Social Anxiety Disorder: Prognostic and Prescriptive Variables · August 2013
Articles (Manuscripts-Versions)
PubMed Central>Journal of Consulting and Clinical Psychology
Amygdala-Frontal Couplings Characterizing SSRI and Placebo Response in Social Anxiety Disorder · August 2014
Articles
International Journal of Neuropsychopharmacology
Clinical Presentation and Pharmacotherapy Response in Social Anxiety Disorder: The Effect of Etiological Beliefs · April 2015
Articles (Manuscripts-Versions)
Europe PMC>Psychiatry Research
Childhood Maltreatment and Social Anxiety Disorder: Implications for Symptom Severity and Response to Pharmacotherapy · November 2011
Articles (Manuscripts-Versions)
PubMed Central>Depression and Anxiety
Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study · May 2016
Articles
Clinical Psychopharmacology and Neuroscience
A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder · June 2008
Articles
Neuropsychopharmacology
Short-Term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia · June 2015
Articles
Iranian Journal of Psychiatry and Behavioral Sciences
A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder · November 2015
Articles
NCBI>Primary Care Companion for CNS Disorders
Antidepressants for Social Anxiety Disorder: A Systematic Review and Meta-Analysis · July 2022
Articles
Neuropsychopharmacology Reports